Insider · CIK 0001781117

MacDonald Kelly

Reports to the SEC for 2 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001781117

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORPU Disposition from Tender	SVP and CFO	UDisposition from Tender	−60.2K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORPA Award	SVP and CFO	AAward	+46.4K sh	—	—	46,430
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORPD Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−46.4K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORPA Award	SVP and CFO	AAward	+42.4K sh	—	—	42,424
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORPD Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−42.4K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)D Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−350K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)D Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−90.5K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)D Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−100K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)D Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−65K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)D Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−70K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitsD Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−15.5K sh	—	—	0
2026-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitsD Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−28.3K sh	—	—	0
2025-12-24	DVAXDYNAVAX TECHNOLOGIES CORPF Tax Payment	SVP and CFO	FTax Payment	−36.1K sh	$15.38	−$556K	60,204
2025-12-23	DVAXDYNAVAX TECHNOLOGIES CORPA Award	SVP and CFO	AAward	+37.5K sh	—	—	66,727
2025-12-23	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+15.5K sh	—	—	82,204
2025-12-23	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+14.1K sh	—	—	96,345
2025-12-23	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−15.5K sh	—	—	15,477
2025-12-23	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−14.1K sh	—	—	28,282
2025-02-18	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+15.5K sh	—	—	34,202
2025-02-18	DVAXDYNAVAX TECHNOLOGIES CORPF Tax Payment	SVP and CFO	FTax Payment	−4,975 sh	$12.93	−$64.3K	29,227
2025-02-18	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−15.5K sh	—	—	30,953
2025-02-13	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+16K sh	—	—	24,043
2025-02-13	DVAXDYNAVAX TECHNOLOGIES CORPF Tax Payment	SVP and CFO	FTax Payment	−5,318 sh	$12.69	−$67.5K	18,725
2025-02-13	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitA Award	SVP and CFO	AAward	+16K sh	—	—	16,000
2025-02-13	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−16K sh	—	—	0
2025-02-13	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	SVP and CFO	AAward	+70K sh	—	—	70,000
2025-02-13	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitA Award	SVP and CFO	AAward	+42.4K sh	—	—	42,424
2025-02-10	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+5,333 sh	—	—	10,040
2025-02-10	DVAXDYNAVAX TECHNOLOGIES CORPF Tax Payment	SVP and CFO	FTax Payment	−1,997 sh	$13.20	−$26.4K	8,043
2025-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−5,333 sh	—	—	0
2024-02-15	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Options (Right to Buy)A Award	SVP and CFO	AAward	+65K sh	—	—	65,000
2024-02-15	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitA Award	SVP and CFO	AAward	+46.4K sh	—	—	46,430
2024-02-12	DVAXDYNAVAX TECHNOLOGIES CORPF Tax Payment	SVP and CFO	FTax Payment	−2,985 sh	$12.82	−$38.3K	4,707
2024-02-10	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+5,333 sh	—	—	7,692
2024-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−5,333 sh	—	—	5,333
2023-02-27	DVAXDYNAVAX TECHNOLOGIES CORPM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+5,334 sh	—	—	5,334
2023-02-27	DVAXDYNAVAX TECHNOLOGIES CORPF Tax Payment	SVP and CFO	FTax Payment	−2,975 sh	$10.36	−$30.8K	2,359
2023-02-27	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−5,334 sh	—	—	10,666
2023-02-16	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	SVP and CFO	AAward	+100K sh	—	—	100,000
2022-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	SVP and CFO	AAward	+90.5K sh	—	—	90,500
2022-02-10	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitA Award	SVP and CFO	AAward	+16K sh	—	—	16,000
2021-03-01	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	SVP and CFO	AAward	+350K sh	—	—	350,000
2020-12-04	IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+5,639 sh	$9.12	+$51.4K	98,680
2020-12-04	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Accounting Officer	SSale	−5,639 sh	$12.50	−$70.5K	93,041
2020-12-04	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−5,639 sh	—	—	0
2020-11-11	IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,561 sh	$9.31	+$33.2K	96,602
2020-11-11	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Accounting Officer	SSale	−3,561 sh	$11.75	−$41.8K	93,041
2020-11-11	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,561 sh	—	—	0
2020-11-09	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Accounting Officer	SSale	−825 sh	$10.92	−$9,009	93,141
2020-11-09	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Accounting Officer	SSale	−100 sh	$10.92	−$1,092	93,041

Recent filings

Accepted (ET)
Feb 104
MacDonald Kelly0001781117-26-000002
SEC(opens sec.gov)
Dec 294
MacDonald Kelly0001628280-25-058992
SEC(opens sec.gov)
Feb 204
MacDonald Kelly0001029142-25-000055
SEC(opens sec.gov)

Companies

Address

C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720

EMERYVILLE, CA, 94608